Michael M Page

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 6

Top Topics

Methicillin Resistant Staphylococcus Aureus

Angiotensin Converting Enzyme

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Journal of chemotherapy (Florence, Italy)

Australian prescriber

Clinical genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Ranita Siru, Johan H Conradie, Melissa J Gillett, Michael M Page
Approach to the diagnosis of secondary hypertension in adults. Australian prescriber 44 (5) (2021)
Michael M Page, Elif I Ekinci, John R Burnett, Amanda J Hooper, Nicola Reid, Warrick Bishop, Chris M Florkowski, Russell Scott, Richard C O'Brien, Gerald F Watts
Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New Zealand. Journal of clinical apheresis 36 (1) (2020)
Natalie C Ward, Michael M Page, Gerald F Watts
Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies. Diabetes, obesity & metabolism (2020)
Emma Fox, Vesa Cheng, Matthew D M Rawlins, John Dyer, Bart De Keulenaer, Michael M Page, Kirsten Hoad, Jason Alexander Roberts
Pharmacokinetics of flucloxacillin during prolonged intermittent renal replacement therapy in a 76-year-old man. Journal of chemotherapy (Florence, Italy) 31 (7-8) (2019)
Michael M Page, Damon A Bell, Gerald F Watts
Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes? Clinical genetics 97 (4) (2019)
Michael M Page, Gerald F Watts
PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease. Diabetes, obesity & metabolism 20 (2) (2017)